EpigenCare, a personalised skin care technology startup, announced on 4th April that it had won the Johnson & Johnson Innovation competition for cutting-edge skin care technologies. Johnson & Johnson, the multinational consumer packaged goods manufacturing company, launched its innovation arm to identify progressive and forward-thinking digital beauty solutions. With a particular focus on personalisation items, it was set up to help consumers make better-informed decisions when it comes to their skin care routines. These leading trends in science and technology come at time, as Lee stated, when consumers are unaware of the true efficacy of skin care products, and when static genetic variants in current personal genomic tests cannot be modified by product ingredients. Focusing on epigenetics, blockchain and AI, Lee discussed an epigenetics-related solution that works by identifying a gene function's level of activity or inactivity. Based in New York, the personal epigenomics and digital biotechnology company is preparing to launch its direct-to-consumer skin care test later in 2018.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We collaborate with the world for the health of everyone in it. Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses.